Safety Syringe Global Market Report 2024

The safety syringe market size has grown strongly in recent years. It will grow from $8.19 billion in 2023 to $8.95 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The growth witnessed during the historical period can be attributed to various factors, including concerns related to needlestick injuries, regulatory mandates, heightened adoption of safety measures, the rising prevalence of blood-borne diseases, and the expansion of healthcare infrastructure.

The safety syringe market size is expected to see strong growth in the next few years. It will grow to $12.6 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The anticipated growth during the forecast period is primarily driven by vaccination initiatives, the growing geriatric population, a heightened focus on preventive healthcare, the expansion of the biopharmaceutical industry, and advancements in material sciences. Key trends expected in this period include rapid technological innovations, a focus on sustainable solutions, the integration of telehealth services, the development of customized solutions for specialized therapeutics, and enhancements in emergency response and preparedness capabilities.

The anticipated rise in blood-borne diseases is poised to drive the expansion of the safety syringe market in the future. Blood-borne diseases, caused by microorganisms such as bacteria, viruses, or parasites transmitted through the blood, pose significant health risks. The adoption of safety syringes represents a proactive approach to safeguarding healthcare workers and patients from these risks, minimizing the chances of accidental exposures and promoting adherence to best practices in medical procedures. For instance, Contagion Live, a US-based news source, reported a 14% increase in blood-borne infection rates in 2020-2021, with 5,023 confirmed cases of hepatitis C virus (HCV) and an estimated 69,800 infections. Additionally, approximately 43 states in the US reported 107,540 newly diagnosed cases of HCV. Consequently, the escalating prevalence of blood-borne diseases serves as a key driver propelling the growth of the safety syringe market.

Major players in the safety syringe market are innovating with new products such as passive needle guards to maintain a competitive advantage. A passive needle guard serves as a safety feature integrated into medical devices such as syringes to enhance safety during and after use. For example, in November 2021, Becton, Dickinson, and Company, a US-based medical device firm, introduced the BD UltraSafe Plus 2.25 mL Passive Needle Guard, expanding its drug delivery systems portfolio. This new solution builds upon the capabilities of the BD UltraSafe Plus needle guard platform, enabling the subcutaneous delivery of biologic solutions with volumes up to 2 mL and viscosities up to 30 cP. The design specifically targets challenges associated with the increasing viscosity and injection volume of biologics, offering a patient-controlled injection option for complex, high-viscosity drugs. The BD UltraSafe Plus 2.25 mL aims to improve the self-injection experience for patients, caregivers, and healthcare providers alike. Moreover, the system is compatible with the BD Neopak 2.25 mL Glass Prefillable Syringe, streamlining support for bio-pharmaceutical drug launches with added convenience and user-friendliness.

In July 2022, Sharps Technology Inc., a medical device company headquartered in the United States, completed the acquisition of a syringe manufacturing facility located in Hungary from SafeGard Medical for $2.5 million. This strategic acquisition is geared towards strengthening Sharps Technology's manufacturing capacities, facilitating the company's transition into revenue-generating commercial activities, and addressing the increasing worldwide demand for its patented smart safety syringes. SafeGard Medical, also based in the US, specializes in emergency medical technologies and training, including the production of safety syringes.

Major companies operating in the safety syringe market report are Cardinal Health Inc., Retractable Technologies Inc., Thermo Fisher Scientific Inc., Medtronic plc, Novo Nordisk A/s, Becton, Dickinson and Company, Baxter International Inc., Boston Scientific Corporation, Medline Industries LP, Terumo Corporation, B. Braun Melsungen AG, West Pharmaceutical Services Inc., Fresenius Kabi AG, Nemera, Smiths Medical International Ltd., Nipro Medical Corporation, Henke-Sass Wolf GmbH, Revolutions Medical iNC., Sol-Millennium Inc., UltiMed Inc., Unilife Corporation, AdvaCare Pharma, Axol Bio Corporation, Vita Needle Company, Numedico Technologies Pty Ltd., Duopross Meditech Corporation, DMC Medical Ltd., Guangdong Haiou Medical Apparatus Co. Ltd., Kendall Healthcare Group Ltd.

North America was the largest region in the safety syringes market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the safety syringe market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the safety syringe market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A safety syringe serves as a medical injection device equipped with integrated safety features to mitigate accidental needle stick injuries or reuse. These syringes are specifically engineered to avert needle stick injuries, which may occur when healthcare workers or individuals inadvertently puncture their skin with a used needle.

Safety syringes primarily comprise retractable safety syringes and non-retractable safety syringes. Retractable safety syringes feature a built-in mechanism enabling the needle to retract or withdraw into the syringe barrel post-injection. They find application in therapies such as insulin, glucagon-like peptide-i (GLP-1), tuberculosis, and growth hormones, catering to subcutaneous and intramuscular administration. These syringes are utilized across various healthcare settings including hospitals, ambulatory surgical centers, long-term care facilities, specialty clinics, among others.

The safety syringe market research report is one of a series of new reports that provides safety syringe market statistics, including safety syringe industry global market size, regional shares, competitors with safety syringe market share, detailed safety syringe market segments, market trends, and opportunities, and any further data you may need to thrive in the safety syringe industry. This safety syringe market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The safety syringe market consists of sales of retractable syringes, needleless syringes, safety syringe accessories, needle removers and blood collection devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.